Matches in SemOpenAlex for { <https://semopenalex.org/work/W2734984966> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2734984966 endingPage "274" @default.
- W2734984966 startingPage "270" @default.
- W2734984966 abstract "Vitacoxib is an imidazole derivative and the novel COX-2 selective inhibitor to be marketed for veterinary use as nonsteroidal anti-inflammatory drugs. No analytical assay to quantify vitacoxib in equine plasma samples has been published to date. In the current study, we aim to develop and validate a brief, quick and sensitive UPLC–MS/MS method for quantification of vitacoxib in equine plasma samples. Plasma samples were precipitated with methyl tert-butyl ether. The Phenomenex column (Kinetex 50 × 2.1 mm i.d. particle size = 2.6 μm, C18, 100 Å) at 25 °C was used in chromatographic separation with mobile phase consisting of acetonitrile and water (containing 0.1% formic acid) at flow rate of 0.4 mL/min. Vitacoxib and internal standard (IS, celecoxib) were detected under the multiple-reaction monitoring mode by mass spectrometer with ESI+ (m/z 347.9/269.03 for vitacoxib and m/z 382.0/362.0 for IS, respectively). The curve concentration range of was 0.5–500 ng/mL with a lower limit of quantification 0.5 ng/mL (r2 = 0.996309) in equine plasma samples. The selectivity, precision, recovery, accuracy, matrix effect and stability under various conditions were conformed to the acceptance requirements. Pharmacokinetic studies of vitacoxib in horses via oral administration (0.1 mg/kg) demonstrated that the procedure was fully validated and successfully. A meaningful basis for assessing the vitacoxib or clinical applications of vitacoxib to horse is provided in the present study." @default.
- W2734984966 created "2017-07-21" @default.
- W2734984966 creator A5008222780 @default.
- W2734984966 creator A5041239331 @default.
- W2734984966 creator A5044480186 @default.
- W2734984966 creator A5059183216 @default.
- W2734984966 creator A5060703774 @default.
- W2734984966 creator A5068761260 @default.
- W2734984966 creator A5075346818 @default.
- W2734984966 creator A5078640736 @default.
- W2734984966 date "2017-09-01" @default.
- W2734984966 modified "2023-09-27" @default.
- W2734984966 title "Determination of vitacoxib, a novel COX-2 inhibitor, in equine plasma using UPLC–MS/MS detection: Development and validation of new methodology" @default.
- W2734984966 cites W1941345656 @default.
- W2734984966 cites W1959800140 @default.
- W2734984966 cites W1987233234 @default.
- W2734984966 cites W1988905992 @default.
- W2734984966 cites W2009228494 @default.
- W2734984966 cites W2021910040 @default.
- W2734984966 cites W2026871317 @default.
- W2734984966 cites W2063551206 @default.
- W2734984966 cites W2080485355 @default.
- W2734984966 cites W2159864435 @default.
- W2734984966 cites W2163756514 @default.
- W2734984966 cites W2073387290 @default.
- W2734984966 doi "https://doi.org/10.1016/j.jchromb.2017.07.024" @default.
- W2734984966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28759842" @default.
- W2734984966 hasPublicationYear "2017" @default.
- W2734984966 type Work @default.
- W2734984966 sameAs 2734984966 @default.
- W2734984966 citedByCount "17" @default.
- W2734984966 countsByYear W27349849662018 @default.
- W2734984966 countsByYear W27349849662019 @default.
- W2734984966 countsByYear W27349849662020 @default.
- W2734984966 countsByYear W27349849662022 @default.
- W2734984966 crossrefType "journal-article" @default.
- W2734984966 hasAuthorship W2734984966A5008222780 @default.
- W2734984966 hasAuthorship W2734984966A5041239331 @default.
- W2734984966 hasAuthorship W2734984966A5044480186 @default.
- W2734984966 hasAuthorship W2734984966A5059183216 @default.
- W2734984966 hasAuthorship W2734984966A5060703774 @default.
- W2734984966 hasAuthorship W2734984966A5068761260 @default.
- W2734984966 hasAuthorship W2734984966A5075346818 @default.
- W2734984966 hasAuthorship W2734984966A5078640736 @default.
- W2734984966 hasConcept C112705442 @default.
- W2734984966 hasConcept C119128265 @default.
- W2734984966 hasConcept C162356407 @default.
- W2734984966 hasConcept C185592680 @default.
- W2734984966 hasConcept C2777379063 @default.
- W2734984966 hasConcept C31827203 @default.
- W2734984966 hasConcept C43617362 @default.
- W2734984966 hasConcept C71043704 @default.
- W2734984966 hasConcept C71924100 @default.
- W2734984966 hasConcept C98274493 @default.
- W2734984966 hasConceptScore W2734984966C112705442 @default.
- W2734984966 hasConceptScore W2734984966C119128265 @default.
- W2734984966 hasConceptScore W2734984966C162356407 @default.
- W2734984966 hasConceptScore W2734984966C185592680 @default.
- W2734984966 hasConceptScore W2734984966C2777379063 @default.
- W2734984966 hasConceptScore W2734984966C31827203 @default.
- W2734984966 hasConceptScore W2734984966C43617362 @default.
- W2734984966 hasConceptScore W2734984966C71043704 @default.
- W2734984966 hasConceptScore W2734984966C71924100 @default.
- W2734984966 hasConceptScore W2734984966C98274493 @default.
- W2734984966 hasFunder F4320321001 @default.
- W2734984966 hasLocation W27349849661 @default.
- W2734984966 hasLocation W27349849662 @default.
- W2734984966 hasOpenAccess W2734984966 @default.
- W2734984966 hasPrimaryLocation W27349849661 @default.
- W2734984966 hasRelatedWork W1571490649 @default.
- W2734984966 hasRelatedWork W2079130042 @default.
- W2734984966 hasRelatedWork W2092328469 @default.
- W2734984966 hasRelatedWork W2148112117 @default.
- W2734984966 hasRelatedWork W2229858648 @default.
- W2734984966 hasRelatedWork W2392271453 @default.
- W2734984966 hasRelatedWork W2791978427 @default.
- W2734984966 hasRelatedWork W28056001 @default.
- W2734984966 hasRelatedWork W3194462057 @default.
- W2734984966 hasRelatedWork W4225985420 @default.
- W2734984966 hasVolume "1061-1062" @default.
- W2734984966 isParatext "false" @default.
- W2734984966 isRetracted "false" @default.
- W2734984966 magId "2734984966" @default.
- W2734984966 workType "article" @default.